Literature DB >> 1541162

Monitoring of serum KL-6 antigen in a patient with radiation pneumonia.

H Hamada1, N Kohno, M Akiyama, K Hiwada.   

Abstract

Serum marker KL-6 antigen has been reported to be a valuable indicator of the disease activity of interstitial pneumonia. It is not clear how sensitive the serum KL-6 antigen level is in reflecting histologic changes in lung tissues. We report here the results of serial measurements of serum KL-6 antigen in a 76-year-old male patient with radiation pneumonia. Serum KL-6 antigen levels were more sensitive than lactate dehydrogenase and procollagen type III N-terminal peptide. The level of serum KL-6 antigen appears to reflect the histologic changes of the lung more sensitively than does C-reactive protein.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1541162     DOI： 10.1378/chest.101.3.858

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  7 in total

1.  Simultaneous measurements of KL-6 and SP-D in patients undergoing thoracic radiotherapy.

Authors:  Yosuke Matsuno; Hiroaki Satoh; Hiroichi Ishikawa; Takahide Kodama; Morio Ohtsuka; Kiyohisa Sekizawa
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

2.  Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis.

Authors:  S Bandoh; J Fujita; Y Ohtsuki; Y Ueda; S Hojo; M Tokuda; H Dobashi; N Kurata; T Yoshinouchi; N Kohno; J Takahara
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

3.  Usefulness of quantifying serum KL-6 levels in the follow-up of uveitic patients with sarcoidosis.

Authors:  Nobuyoshi Kitaichi; Toshihide Ariga; Satoru Kase; Kauzhiko Yoshida; Kenichi Namba; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-23       Impact factor: 3.117

4.  KL-6 as a Biomarker of Interstitial Lung Disease Development in Patients with Sjögren Syndrome: A Retrospective Case-Control Study.

Authors:  Yu-Hsiang Chiu; Chen-Chih Chu; Chun-Chi Lu; Feng-Cheng Liu; Shin-En Tang; Shi-Jye Chu; San-Yuan Kuo; Hsiang-Cheng Chen
Journal:  J Inflamm Res       Date:  2022-04-08

5.  Increase of KL-6 in sera of uveitis patients with sarcoidosis.

Authors:  Nobuyoshi Kitaichi; Satoshi Kotake; Hitoshi Shibuya; Yukiho Yamada; Hitoshi Chiba; Kenichi Namba; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-11       Impact factor: 3.117

6.  Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II.

Authors:  Miriana d'Alessandro; Laura Bergantini; Dalila Cavallaro; Sara Gangi; Paolo Cameli; Edoardo Conticini; Bruno Frediani; Francesco Dotta; Elena Bargagli
Journal:  Int J Environ Res Public Health       Date:  2022-02-15       Impact factor: 3.390

7.  A new serum tumor marker, CAM 123-6, highly specific to pulmonary adenocarcinoma.

Authors:  H Hamada; N Kohno; K Hiwada
Journal:  Jpn J Cancer Res       Date:  1994-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.